Informed consent and biological agents in rheumatology and internal medicine
Background The need for highly effective therapies in rheumatologic diseases has led to the widespread and growing use of a heterogeneous class of molecules called biological agents. The increasing experience with biological agents has raised concerns about safety and efficacy issues that need to be...
Saved in:
Published in | European journal of clinical investigation Vol. 52; no. 9; pp. e13805 - n/a |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!